Copyright
        ©The Author(s) 2025.
    
    
        World J Gastrointest Pharmacol Ther. Sep 5, 2025; 16(3): 108257
Published online Sep 5, 2025. doi: 10.4292/wjgpt.v16.i3.108257
Published online Sep 5, 2025. doi: 10.4292/wjgpt.v16.i3.108257
            Table 1 Biochemical tests before and after initiating odevixibat
        
    | Blood test | Result before initiating treatment | Result 8 months after initiating treatment | Result 12 months after initiating treatment | Result 16 months after initiating treatment | 
| Total bilirubin (normal range < 17 μmol/L) | 208.4 | 145.6 | 192 | 251 | 
| Direct bilirubin (normal range < 5 μmol/L) | 192.2 | 135.5 | 172 | 214 | 
| Alanine aminotransferase (normal range < 41 IU/L) | 183 | 113 | 146 | 194 | 
| Aspartate aminotransferase (normal range < 41 IU/L) | 245 | 160 | 200 | 277 | 
| Bile acids (normal range < 10 μmol/L) | 257 | 139 | 223 | 115 | 
| International normalized ratio (normal range 0.7-1.1 seconds) | 1.3 | 1.2 | 1.2 | 1.2 | 
| Albumin (normal range 35-52 g/L) | 31 | 35 | 35 | 37 | 
| Platelet [normal range (140-400) × 109/L] | 182 | 328 | 267 | 165 | 
- Citation: Al Atrash E, Bitar R. Odevixibat improves pruritus and bile acid level in Alagille syndrome: A case report. World J Gastrointest Pharmacol Ther 2025; 16(3): 108257
- URL: https://www.wjgnet.com/2150-5349/full/v16/i3/108257.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v16.i3.108257

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                        